Liver Cancer
Copyright ©The Author(s) 2003.
World J Gastroenterol. Oct 15, 2003; 9(10): 2194-2197
Published online Oct 15, 2003. doi: 10.3748/wjg.v9.i10.2194
Table 2 Pathologic data
Clinical parametersGroup A (n = 78)Group B (n = 176)
The mass
Median diameter (cm)11.58 (6.2-24.6)a6.25 (1.8-12.7)
> or = 5 cm72 (92.30%)a118 (67.05%)
> or = 10 cm53 (67.95%)a28 (15.90%)
Close or invade vana cana23 (29.49%)a17 (9.65%)
Close or invade major21 (26.92%)a13 (7.39%)
hepatic vein
Close or invade major bile duct11 (14.10%)a8 (4.55%)
Close or invade major port vein32 (41.03%)a22 (12.5%)
TNM tumor stage
Stage 16 (7.69%)a49 (27.84%)
Stage 212 (15.38%)a71 (40.34%)
Stage 336 (46.15%)a32 (18.19%)
Stage 4a20 (25.64%)a22 (12.5%)
Stage 4b4 (5.13%)a2 (1.14%)
Cirrhosis59 (75.64%)120 (68.18%)
Multiple tumor8 (10.25%)a6 (3.41%)
Caudate lobe tumor4 (5.13%)a0 (0)
Tumor free resection margin74 (94.87%)173 (98.3%)
Tumor rupture during operation11 (14.10%)a13 (7.39%)